findmyKOL
Clinical trialNCT00553423UnknownPhase 3Interventional

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

SponsorAga Khan UniversityEnrollment128Encephalopathy, HepaticEncephalopathy, HepatocerebralHepatocerebral EncephalopathyPortal-Systemic Encephalopathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan
  • Aga Khan University

    Karachi, Sindh, Pakistan

    Recruiting
  • Aga Khan University

    Karachi, Sindh, Pakistan

    Mohammad Salih, FCPSShahid Ahmed, FCPSShahid Majid, FCPSWasim Jafri, FRCP, FACG
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2007
Primary completion
—
Completion
30 Nov 2008
Last update posted
5 Nov 2007
Registered enrollment
128
Registry id
NCT00553423
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.